Focosi, D.; Tuccori, M.; Baj, A.; Maggi, F.
SARS-CoV-2 Variants: A Synopsis of In Vitro Efficacy Data of Convalescent Plasma, Currently Marketed Vaccines, and Monoclonal Antibodies. Viruses 2021, 13, 1211.
https://doi.org/10.3390/v13071211
AMA Style
Focosi D, Tuccori M, Baj A, Maggi F.
SARS-CoV-2 Variants: A Synopsis of In Vitro Efficacy Data of Convalescent Plasma, Currently Marketed Vaccines, and Monoclonal Antibodies. Viruses. 2021; 13(7):1211.
https://doi.org/10.3390/v13071211
Chicago/Turabian Style
Focosi, Daniele, Marco Tuccori, Andreina Baj, and Fabrizio Maggi.
2021. "SARS-CoV-2 Variants: A Synopsis of In Vitro Efficacy Data of Convalescent Plasma, Currently Marketed Vaccines, and Monoclonal Antibodies" Viruses 13, no. 7: 1211.
https://doi.org/10.3390/v13071211
APA Style
Focosi, D., Tuccori, M., Baj, A., & Maggi, F.
(2021). SARS-CoV-2 Variants: A Synopsis of In Vitro Efficacy Data of Convalescent Plasma, Currently Marketed Vaccines, and Monoclonal Antibodies. Viruses, 13(7), 1211.
https://doi.org/10.3390/v13071211